ADIM
GH icon

Alpha DNA Investment Management’s Guardant Health GH Stock Holding History

Alpha DNA Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,364
Closed -$497K – 217
2023
Q4 		$497K Sell
18,364
-3,202
-15% -$84K 0.19% 128
2023
Q3 		$639K Buy
+21,566
New +$758K 0.26% 80

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Alpha DNA Investment Management's GH Position: Q1 2024 in Review

Alpha DNA Investment Management sold out of Guardant Health (GH) in Q1 2024, closing a stake of 18,364 shares — an estimated $497K sold.

Alpha DNA Investment Management first reported a position in GH in Q3 2023 and held it in 2 quarters. The position peaked at $639K in Q3 2023. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Alpha DNA Investment Management reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 18,364 Guardant Health shares in Q1 2024, an estimated $497K.
  • Alpha DNA Investment Management first reported a position in Guardant Health in Q3 2023 and held it in 2 quarters.
  • Alpha DNA Investment Management's Guardant Health position peaked at $639K in Q3 2023.
  • 258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Alpha DNA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.